Published • loading... • Updated
Cardinal Health, Shine Technologies amp up domestic production of radio-pharmaceuticals
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cardinal Health, Shine Technologies amp up domestic production of radio-pharmaceuticals
DUBLIN, Ohio — As demand for radiopharmaceuticals and nuclear medicine increases, US-based producers are aiming to meet the moment.Radiopharmaceuticals are radioactive treatments that can diagnose and treat cancer. One of the US’s largest manufacturers, Cardinal Health, announced today that it’s expanding its production of actinium-225, a radionuclide used for cancer treatment, at a facility in Indianapolis, Indiana. The news comes on the heels …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
